- REPORT SUMMARY
- TABLE OF CONTENTS
-
Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.
The report details the trend, potential and market size of Prostate Cancer Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Prostate Cancer Treatmentmarket, defines the market attractiveness level of Prostate Cancer Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Prostate Cancer Treatment industry, describes the types of Prostate Cancer Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prostate Cancer Treatment market and the development prospects and opportunities of Prostate Cancer Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prostate Cancer Treatment market in Chapter 13.
By Player:
Takeda Pharmaceutical Company Ltd
Bayer AG
Bristol-Myers Squibb Company
AstraZeneca plc
Johnson & Johnson
GlaxoSmithKline Plc
F Hoffmann-La Roche AG
Astellas Pharma Inc
Ferring Pharmaceuticals Inc
Ipsen Pharma
By Type:
Biological Therapy
Chemotherapy
By End-User:
Hospital
Research Institution
Clinic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Prostate Cancer Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Prostate Cancer Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Prostate Cancer Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Prostate Cancer Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Prostate Cancer Treatment Market Analysis and Outlook to 2022
-
7.1 Global Prostate Cancer Treatment Consumption (2017-2022)
-
7.2 United States Prostate Cancer Treatment Consumption (2017-2022)
-
7.3 Europe Prostate Cancer Treatment Consumption (2017-2022)
-
7.4 China Prostate Cancer Treatment Consumption (2017-2022)
-
7.5 Japan Prostate Cancer Treatment Consumption (2017-2022)
-
7.6 India Prostate Cancer Treatment Consumption (2017-2022)
-
7.7 South Korea Prostate Cancer Treatment Consumption (2017-2022)
8 Region and Country-wise Prostate Cancer Treatment Market Analysis and Outlook to 2028
-
8.1 Global Prostate Cancer Treatment Consumption Forecast (2022-2028)
-
8.2 United States Prostate Cancer Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Prostate Cancer Treatment Consumption Forecast (2022-2028)
-
8.4 China Prostate Cancer Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Prostate Cancer Treatment Consumption Forecast (2022-2028)
-
8.6 India Prostate Cancer Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Prostate Cancer Treatment Consumption Forecast (2022-2028)
9 Global Prostate Cancer Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Prostate Cancer Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biological Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Prostate Cancer Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Institution Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)
10 Global Prostate Cancer Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Prostate Cancer Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biological Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Prostate Cancer Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Institution Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
11 Global Prostate Cancer Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Prostate Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Prostate Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Prostate Cancer Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Prostate Cancer Treatment Market Competitive Analysis
-
14.1 Takeda Pharmaceutical Company Ltd
-
14.1.1 Takeda Pharmaceutical Company Ltd Company Details
-
14.1.2 Takeda Pharmaceutical Company Ltd Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Pharmaceutical Company Ltd Prostate Cancer Treatment Product and Service
-
14.2 Bayer AG
-
14.2.1 Bayer AG Company Details
-
14.2.2 Bayer AG Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer AG Prostate Cancer Treatment Product and Service
-
14.3 Bristol-Myers Squibb Company
-
14.3.1 Bristol-Myers Squibb Company Company Details
-
14.3.2 Bristol-Myers Squibb Company Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Company Prostate Cancer Treatment Product and Service
-
14.4 AstraZeneca plc
-
14.4.1 AstraZeneca plc Company Details
-
14.4.2 AstraZeneca plc Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca plc Prostate Cancer Treatment Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Prostate Cancer Treatment Product and Service
-
14.6 GlaxoSmithKline Plc
-
14.6.1 GlaxoSmithKline Plc Company Details
-
14.6.2 GlaxoSmithKline Plc Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline Plc Prostate Cancer Treatment Product and Service
-
14.7 F Hoffmann-La Roche AG
-
14.7.1 F Hoffmann-La Roche AG Company Details
-
14.7.2 F Hoffmann-La Roche AG Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 F Hoffmann-La Roche AG Prostate Cancer Treatment Product and Service
-
14.8 Astellas Pharma Inc
-
14.8.1 Astellas Pharma Inc Company Details
-
14.8.2 Astellas Pharma Inc Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Astellas Pharma Inc Prostate Cancer Treatment Product and Service
-
14.9 Ferring Pharmaceuticals Inc
-
14.9.1 Ferring Pharmaceuticals Inc Company Details
-
14.9.2 Ferring Pharmaceuticals Inc Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Ferring Pharmaceuticals Inc Prostate Cancer Treatment Product and Service
-
14.10 Ipsen Pharma
-
14.10.1 Ipsen Pharma Company Details
-
14.10.2 Ipsen Pharma Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Ipsen Pharma Prostate Cancer Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Prostate Cancer Treatment
-
Figure Prostate Cancer Treatment Picture
-
Table Global Prostate Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prostate Cancer Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prostate Cancer Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Prostate Cancer Treatment Consumption by Country (2017-2022)
-
Figure United States Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biological Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institution Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Biological Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Prostate Cancer Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Prostate Cancer Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda Pharmaceutical Company Ltd (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Ltd Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Ltd Prostate Cancer Treatment Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Prostate Cancer Treatment Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Prostate Cancer Treatment Product and Service
-
Table AstraZeneca plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca plc Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca plc Prostate Cancer Treatment Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Prostate Cancer Treatment Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Prostate Cancer Treatment Product and Service
-
Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche AG Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche AG Prostate Cancer Treatment Product and Service
-
Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Inc Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Prostate Cancer Treatment Product and Service
-
Table Ferring Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Ferring Pharmaceuticals Inc Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Pharmaceuticals Inc Prostate Cancer Treatment Product and Service
-
Table Ipsen Pharma (Foundation Year, Company Profile and etc.)
-
Table Ipsen Pharma Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Pharma Prostate Cancer Treatment Product and Service
-